WARNER CHILCOTT PLC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 22 rows in 2010. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2010-09-30: Reporting owner Fitzgerald Liam M.; Form 4; Security Option to purchase ordinary shares, par value $0.01; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2010-09-30: Reporting owner Gilligan Claire A; Form 4; Security Option to purchase ordinary shares par value $0.01 per share; Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2010-08-13: Reporting owner BLOEM JAMES H; Form 4; Security Option to purchase ordinary shares, par value $0.01; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2010-08-13: Reporting owner BLOEM JAMES H; Form 4; Security Option to purchase ordinary shares, par value $0.01; Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2010-09-30 | Fitzgerald Liam M. Director | 4 | Option to purchase ordinary shares, par value $0.01 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,970 8,970 owned after | $22.44 exercise price | 2010-10-01 | |
| 2010-09-30 | Gilligan Claire A Officer (Senior V.P. Global Quality) | 4 | Option to purchase ordinary shares par value $0.01 per share Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +5,330 5,330 owned after | $22.44 exercise price | 2010-10-01 | |
| 2010-08-13 | BLOEM JAMES H Director | 4 | Option to purchase ordinary shares, par value $0.01 Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −1,781 0 owned after | $16.66 exercise price | 2010-08-17 | |
| 2010-08-13 | BLOEM JAMES H Director | 4 | Option to purchase ordinary shares, par value $0.01 Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,095 0 owned after | $17.51 exercise price | 2010-08-17 | |
| 2010-08-13 | BLOEM JAMES H Director | 4 | Option to purchase ordinary shares, par value $0.01 Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,300 0 owned after | $16.01 exercise price | 2010-08-17 | |
| 2010-07-28 holding as of filing | Gilligan Claire A Officer (Senior V.P. Global Quality) | 3 | Option to purchase ordinary shares par value $0.01 per share Derivative · Direct | Holding | $15.00 exercise price | 2010-07-28 | ||
| 2010-07-28 holding as of filing | Gilligan Claire A Officer (Senior V.P. Global Quality) | 3 | Option to purchase ordinary shares par value $0.01 per share Derivative · Direct | Holding | $17.64 exercise price | 2010-07-28 | ||
| 2010-07-28 holding as of filing | Gilligan Claire A Officer (Senior V.P. Global Quality) | 3 | Option to purchase ordinary shares par value $0.01 per share Derivative · Direct | Holding | $13.29 exercise price | 2010-07-28 | ||
| 2010-07-28 holding as of filing | Gilligan Claire A Officer (Senior V.P. Global Quality) | 3 | Option to purchase ordinary shares par value $0.01 per share Derivative · Direct | Holding | $27.33 exercise price | 2010-07-28 | ||
| 2010-05-13 | BLOEM JAMES H Director | 4 | Option to purchase ordinary shares, par value $0.01 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,640 9,640 owned after | $25.68 exercise price | 2010-05-17 | |
| 2010-05-13 | KING JOHN A Director | 4 | Option to purchase ordinary shares, par value $0.01 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,640 9,640 owned after | $25.68 exercise price | 2010-05-17 | |
| 2010-05-13 | O'Sullivan Patrick J Director | 4 | Option to purchase ordinary shares, par value $0.01 Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +9,640 9,640 owned after | $25.68 exercise price | 2010-05-17 | |
| 2010-03-31 | van Zoonen Marinus Johannes Officer (Pres., Europe/Int'l&Glob. Mkt.) | 4 | Option to purchase ordinary shares par value $0.01 per share Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +13,726 13,726 owned after | $25.52 exercise price | 2010-04-09 | |
| 2010-01-29 | Herendeen Paul Officer (Exec. V.P. and CFO) | 4 | Option to purchase ordinary shares par value $0.01 per share Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +56,710 56,710 owned after | $27.33 exercise price | 2010-02-02 | |
| 2010-01-29 | Cross Leland H Officer (Senior V.P., Tech. Operations) | 4 | Option to purchase ordinary shares par value $0.01 per share Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,040 15,040 owned after | $27.33 exercise price | 2010-02-02 | |
| 2010-01-29 | Ellman Herman Officer (Senior V.P., Clinical Devel.) | 4 | Option to purchase ordinary shares par value $0.01 per share Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,040 15,040 owned after | $27.33 exercise price | 2010-02-02 | |
| 2010-01-29 | Boissonneault Roger M Director, Officer (CEO & President) | 4 | Option to purchase ordinary shares par value $0.01 per share Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +216,810 216,810 owned after | $27.33 exercise price | 2010-02-02 | |
| 2010-01-29 | Bruno Anthony D Officer (Exec. V.P., Corp. Development) | 4 | Option to purchase ordinary shares par value $0.01 per share Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +56,710 56,710 owned after | $27.33 exercise price | 2010-02-02 | |
| 2010-01-29 | Reichel Carl W Officer (President, Pharmaceuticals) | 4 | Option to purchase ordinary shares par value $0.01 per share Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +56,710 56,710 owned after | $27.33 exercise price | 2010-02-02 | |
| 2010-01-29 | Hara Izumi Officer (Sr. VP, Gen. Counsel & Sec.) | 4 | Option to purchase ordinary shares par value $0.01 per share Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +16,510 16,510 owned after | $27.33 exercise price | 2010-02-02 | |
| 2010-01-29 | Howard Alvin D Officer (Sr. V.P., Regulatory Affairs) | 4 | Option to purchase ordinary shares par value $0.01 per share Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,040 15,040 owned after | $27.33 exercise price | 2010-02-02 | |
| 2010-01-29 | van Zoonen Marinus Johannes Officer (Pres., Europe/Int'l&Glob. Mkt.) | 4 | Option to purchase ordinary shares par value $0.01 per share Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +43,749 43,749 owned after | $27.33 exercise price | 2010-02-02 |